Skip to content

Establishing a New Protocol for Early Mucositis and Peri-implantitis Treatment Using an Air-polishing Device

Establishing a New Protocol for Early Mucositis and Peri-implantitis Treatment Using an Air-polishing Device

Status
Withdrawn
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03348111
Acronym
PERIFLOW
Enrollment
0
Registered
2017-11-20
Start date
2019-06-30
Completion date
2021-06-30
Last updated
2020-08-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Mucositis, Peri-Implantitis

Keywords

Mucositis, Peri-Implantitis, Air-Flow Master Piezon®

Brief summary

Considering the frequent occurence of peri-implantitis and mucositis, a multiple of treatment alternatives have been proposed including non-surgical and surgical procedures. However, it seems that the most effective treatment remains prevention of these diseases. The aim of this study is to emphasize on mucositis and peri-implantitis prevention using an air abrasion device the Air-Flow Master Piezon® with erythritol and chlorhexidine powder in order to eliminate and / or disorganize the biofilm responsible for peri-implant mucosa inflammation.

Detailed description

Peri-implant infections (mucositis and peri-implantitis) depict an increasing focus in dental practice and implantology. mean prevalence of mucositis is of 43% and periimplantitis of 22%. Consequences for the implant without successful treatment range from local reversible inflammation (mucositis) to implant loss (periimplantitis). These lead to functional, social and esthetic prejudices for patients. The main factor for establishment of peri-implant infections is the formation and maturation of the bacterial biofilm. Peri-implantitis and mucositis treatment require the removal of the bacterial biofilm and the disinfection of the implant surface. Because of special surface conditions and structures, it is more difficult to remove bacterial biofilms from implant surfaces than teeth. the key to controlling the inflammation due to the bacterial biofilm is to prevent its installation and progression. The procedure tested in this study is an air abrasion device, the Air-Flow Master Piezon® with erythritol and chlorhexidine powders on implants presenting clinical and radiographic signs of mucositis and peri-implantitis along with renewal of local oral hygiene instructions in order to reduce the inflammation locally by disorganizing and eliminating the biofilm. Follow-up of the patients will be held every 2 months for 6 months by scoring the bleeding on probing, the plaque index and measuring clinical attachment level in order to compare it with the initial measure. At 6 month an X-ray will also enable to compare bone level and mineralization. This initial study will help establish a standardized protocol for peri-implant infection management.

Interventions

DEVICEAir-polishing device

Air abrasion using the Air-Flow Master Piezon® with erythritol and Chlorhexidine powders on implants presenting clinical and radiographic signs of mucositis and peri-implantitis along with renewal of local oral hygiene instructions in order to reduce the inflammation locally

Sponsors

University Hospital, Toulouse
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* adult patients, * possessing one or more implants prosthetically engaged with local peri-implant mucosa inflammation assessed by bleeding on probing * affiliated with a social security scheme

Exclusion criteria

* patients with implant mobility or implants associated with vestibular cellulitis * not available patients for the follow-up visits * patients with known allergy to erythritol and/or Chlorhexidine powder * patients with chronic bronchitis * patients with asthma * patients with endocarditis * patients with contagious disease * patients with immunodeficiency * patients under radiotherapy and/or chemotherapy and/or antibiotics * not mastery of plaque control on the part of the patient (after education) * subjects under legal protection * pregnant or breastfeeding women

Design outcomes

Primary

MeasureTime frameDescription
Change from baseline peri-implant inflammation at 6 months6 monthsbleeding on probing (binary criteria : yes/no)
Change from baseline peri-implant inflammation at 4 months4 monthsbleeding on probing (binary criteria : yes/no)
Change from baseline peri-implant inflammation at 2 months2 monthsbleeding on probing (binary criteria : yes/no)

Secondary

MeasureTime frameDescription
stability of the bone level6 monthsbone level assessed by X-ray
Quality of life with the Geriatric Oral Health Assessment Index (GOHAI)6 monthsThe Geriatric Oral Health Assessment Index (GOHAI) is a self-reported measure designed to assess the oral health problems of older adults
clinical attachment gain2 monthsThe measurement of the probing depth and of the eventual recession (compared to Baseline) allows to assess the clinical attachment gain
Quality of life with Oral Health Assessment Tool (OHAT)6 monthsThe Oral Health Assessment Tool (OHAT) was a component of the Best Practice Oral Health Model for Australian Residential Care study. The OHAT provided institutional carers with a simple, eight category screening tool to assess residents' oral health, including those with dementia

Countries

France

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026